GLP1R and Wolfram syndrome: Although the current management of Wolfram syndrome remains supportive, emerging strategies targeting endoplasmic reticulum calcium homeostasis, protein folding, and oxidative stress, such as dantrolene, chemical chaperones, GLP‐1 receptor agonists, and gene therapy, hold promise for modifying disease progression [6].